Literature DB >> 11727003

Liver transplantation: evolving patient selection criteria.

A S Yu1, A Ahmed, E B Keeffe.   

Abstract

The widespread recognition of the success of liver transplantation as a treatment for most types of acute and chronic liver failure has led to increased referrals for transplantation in the setting of a relatively fixed supply of cadaver donor organs. These events have led to a marked lengthening of the waiting time for liver transplantation, resulting in increased deaths of those on the waiting list and sicker patients undergoing transplantation. Nearly 5000 liver transplantations were performed in the United States in 2000, while the waiting list grew to over 17,000 patients. The mounting disparity between the number of liver transplant candidates and the limited supply of donor organs has led to reassessment of the selection and listing criteria for liver transplantation, as well as revision of organ allocation and distribution policies for cadaver livers. The development of minimal listing criteria for patients with chronic liver disease based on a specific definition for decompensation of cirrhosis has facilitated the more uniform listing of patients at individual centres across the United States. The United Network for Organ Sharing, under pressure from transplant professionals, patient advocacy groups and the federal government, has continuously revised allocation and distribution policies based on the ethical principles of justice for the individual patient versus optimal utility of the limited organ supply available annually. Beginning in 2002, it is likely that the Model for End-stage Liver Disease (MELD) score will be implemented to determine disease severity and direct donor organs to the sickest patients rather than to those with the longest waiting times.

Entities:  

Mesh:

Year:  2001        PMID: 11727003     DOI: 10.1155/2001/743019

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  9 in total

1.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

2.  Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients.

Authors:  H Egawa; K Ozawa; Y Takada; S Teramukai; A Mori; K Ogawa; T Kaido; Y Fujimoto; Y Kawaguchi; E Hatano; H Sato; M Ono; K Takai; K Tanaka; S Uemoto
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

3.  Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis.

Authors:  Fei Liu; Bo Li; Wen-Tao Wang; Yong-Gang Wei; Lv-Nan Yan; Tian-Fu Wen; Ming-Qing Xu; Jia-Yin Yang
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

4.  Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.

Authors:  Cheng-Lin Zhu; Qiang Huang; Chen-Hai Liu; Fang Xie
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

Review 5.  Liver transplantation as a management of hepatocellular carcinoma.

Authors:  Ayman Zaki Azzam
Journal:  World J Hepatol       Date:  2015-06-08

6.  Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto; K Ogawa
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

7.  Serial assessment of immune status by circulating CD8 effector T cell frequencies for posttransplant infectious complications.

Authors:  Shinji Uemoto; Kazue Ozawa; Hiroto Egawa; Yasutsugu Takada; Hiroshi Sato; Satoshi Teramukai; Mureo Kasahara; Kohei Ogawa; Masako Ono; Kenji Takai; Masanori Fukushima; Kayo Inaba; Koichi Tanaka
Journal:  Clin Dev Immunol       Date:  2008

8.  Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.

Authors:  Hiroto Egawa; Kazue Ozawa; Yasutsugu Takada; Satoshi Teramukai; Akira Mori; Mureo Kasahara; Kohei Ogawa; Yasuhiro Ogura; Fumitaka Oike; Toshimi Kaido; Masako Ono; Hiroshi Sato; Kenji Takai; Shinji Uemoto
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

9.  Impact of age on the incidence of complications after liver transplantation: A single-center retrospective study.

Authors:  Ju Yeon Park; Yoon Ji Choi; Hyun-Su Ri; Jung Min Lee; Hyo Jung Son; Yoon Sook Lee; Je Ho Ryu; Kwang Ho Yang
Journal:  Braz J Anesthesiol       Date:  2021-03-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.